12 April 2024
The Evers company has registered a new medical product: an ointment mesh sterile dressing for wound healing. Production of this product has already commenced at the company’s facility, with a staggering target of manufacturing 40,000 units monthly.
As specified, investments in the project amounted to 11 million rubles. The bandage is an atraumatic rectangular polyester mesh impregnated with a medicinal ointment composition. It is based on copper and zinc. The mesh is designed to fit any complex wound, without adhering to the wound surface and without causing any discomfort when removed or replaced. It is noted that the ointment base of the dressing prevents the entry of microorganisms.
PrintVaccination against the plague using a Russian drug is currently being carried out in Mongolia
24 July 2024
24 July 2024
Russia will conduct an experiment to block the supply of low-quality products to hospitals
23 July 2024
With seventh person seemingly cured of HIV, signs of hope for a broader cure
23 July 2024